GEM-132

N/A

Report date: 2023/02/18 23:49:07
NME

Base Information

Drug NameGEM-132
Drug Alias NameGene Expression Modulator 132GEM-132
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGene expression modulators
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus InfectionsCytomegalovirus Retinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIdera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdera
Active IndicationsN/A
Inactive IndicationsCytomegalovirus InfectionsCytomegalovirus Retinitis

Other Information

ATC CodeN/A
Related LinksN/A